期刊文献+

糖尿病视网膜病变激光面积与疗效的分析 被引量:14

Association between percentage of areas of laser photocoagulation and efficacy of laser treatment in diabetic retinopathy
在线阅读 下载PDF
导出
摘要 目的通过自行设计的计算机软件量化激光斑面积,计算糖尿病视网膜病变(diabetic retinopathy,DR)患者全视网膜光凝(panretinal photocoagulation,PRP)后激光斑所占眼底图总面积百分比,探讨激光斑面积与视力及黄斑厚度、黄斑容积之间的关系。方法选择重度非增生性DR患者30例60眼行PRP治疗。将不伴有黄斑水肿的患者分为A、B两组,每组24眼;将伴有黄斑水肿的患者分为C、D两组,每组6眼。其中A、B两组行PRP,C、D两组先行黄斑格栅样光凝,1周后再行PRP;A组、C组PRP间隔1个激光斑;B组、D组PRP间隔2个激光斑。记录PRP前、PRP后3个月各组视力及黄斑厚度、黄斑容积,并测量4组眼底激光斑面积占眼底图总面积的百分比,比较激光斑面积比值与激光治疗效果的关系。结果 PRP间隔1个激光斑时,激光斑面积(像素)为20000~50000(34398.27±8808.51),激光斑面积与眼底图总面积的百分比为(32.64±4.43)%(25%~40%)。PRP间隔2个激光斑时,激光斑面积为10000~20000(15442.33±2737.77),激光斑面积与眼底图总面积的百分比为(18.35±3.43)%(10%~25%)。A组与B组比较,PRP后视力、黄斑厚度及黄斑容积差异均无统计学意义(均为P>0.05);C组与D组比较,PRP后视力恢复更好,黄斑厚度及黄斑容积均有显著降低(均为P<0.05)。结论有效的激光斑面积是PRP治疗成功的关键,对于伴有黄斑水肿的重度非增生性DR患者,激光斑所占视网膜总面积为25%~40%时,术后视力及黄斑厚度、黄斑容积恢复较好。 Objective To calculate the percentage of retinal areas after panretinal photocoagulation( PRP) by ourselves developed software,and explore the association between the laser spot area with visual acuity( VA) ,macular thickness and macular volume in patients with diabetic retinopathy ( DR) .Methods Thirty patients ( 60 eyes) with server non-proliferation DR were selected.Those without ME were divided into group A ( 24 eyes) and group B ( 24 eyes) ,and those with ME divided into group C ( 6 eyes) and group D ( 6 eyes) .Group A and Group B were treated with PRP.Group C and D were first treated with macular grid photocoagulation,then treated with PRP 1 week later.Group A and group C were treated with a distance of 1 laser spot between every two laser spots,while group B and group D with a distance of 2 laser spot.The macular thickness, macular volume and VA of each group at 3 months before and after PRP were recorded, and the percentage of the laser spot area in the whole area of eye ground was measured, then association between the laser spot area ratio and the effect of laser treatment was explored.Results The laser spot size ( pixel) ranged from 20 000 to 50 000 ( 34 398.27±8808.51) and the laser spot area ratio was from 25% to 40% ( 32.64±4.43) % when the interval was one laser spot distance.The laser spot size ranged from 10 000 to 20 000 ( 15 442.33±2737.77) and the laser spot area ratio was from 10% to 25% ( 18.35±3.43) % when the interval was two laser spots distance.There was no significant difference between VA,macular thickness and macular volume of group A and group B after PRP( all P 0.05) ,while there were significant differences between VA,macular thickness and macular volume between group C and group D( all P 0.05) .Conclusion Effective laser spot area is the key to a successful treatment for PRP.VA,macular thickness and macular volume improve best when the laser spot area ratio is from 25% to 40%.
出处 《眼科新进展》 CAS 北大核心 2013年第2期165-168,共4页 Recent Advances in Ophthalmology
关键词 糖尿病视网膜病变 全视网膜光凝 光学相干断层扫描 激光斑面积 diabetic retinopathy panretinal photocoagulation optical coherence tomography laser facula area
作者简介 李朝晖,女,1975年4月出生,吉林四平人,硕士研究生,副主任医师,吉林省眼科医师协会委员,吉林省中西医结合眼科分会委员。联系电话:15843100600;E—mail:156302397@qq.com
  • 相关文献

参考文献11

  • 1Wang XY, Wang T, Bu J. Color image segmentation using pixel wise support vector machine classification [ J ]. Pattern Recog- nit.2011.44(4) :777-787.
  • 2Zhang Y, Rockett PI. The Bayesian operating point of the Canny edge detector [J]. IEEE Trans Image Process, 2005, 15 ( 11) : 3409-3416.
  • 3Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angio- grams[ J]. Ophthalmology, 1991,98 (5 Suppl) :807-822.
  • 4郑志.糖尿病视网膜病变临床防治:进展、挑战与展望[J].中华眼底病杂志,2012,28(3):209-214. 被引量:142
  • 5Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9 [ J ]. Ophthalmology, 1991,98 ( 5 Suppl) : 766-785.
  • 6刘晓玲,孙心铨.重视糖尿病视网膜病变以及眼底病激光光凝的规范化治疗[J].中华眼底病杂志,2010,26(2):101-104. 被引量:55
  • 7The Diabetic Retinopathy Study Research Group. Indications for photocoagulation treatment of diabetic retinopathy [ J ]. Int Oph- thalmol Clin, 1987,27 (4) :239-253.
  • 8Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagula- tion of diabetic macuiar edema [ J ]. Ophthalmology, 1987,94 (7) :761-774.
  • 9Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W,et al. Optical coherence tomography [ J]. Science, 1991,254 (5035) :1178-1181.
  • 10Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography[J]. Arch Ophthalmol, 2005,124 (2) :193-198.

二级参考文献26

  • 1Klein R,Klein BE,Moss SE.Visual impairment in diabetes,Ophthalmology,1984,91:1-9.
  • 2Early Treatment Diabetic Retinopathy Study Research Group.Photocoagulation treatment of proliferative diabetic retinopathy.Ophthalmology,1981,88:583-600.
  • 3Early Treatment Diabetic Retinopathy Study Research Group.Photocoagulation for diabetic macular edema,early treatment diabetic retinopathy study report number 1.Arch Ophthalmol,1985,103:1796-1806.
  • 4Early Treatment Diabetic Retinopathy Study Research Group.Early photocoagulation for diabetic retinopathy:ETDRS report number 9.Ophthalmology,1991,98:766-785.
  • 5Early Treatment Diabetic Retinopathy Study Research Group.Focal photocoagulation treatment of diabetic macular edema,relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline:ETDRS report number 19.Arch Ophthalmol,1995,113:1144-1155.
  • 6El-Asrar AM,Al-Mezaine HS,Ola MS.Changing paradigms in the treatment of diabetic retinopathy.Curr Opin Ophthalmol,2009,20:532-538.
  • 7孙心铨.努力提高、规范激光治疗技术,造福于更多的眼底病患者//宗淑杰,吴明江,秦银河,等.医家金鉴.北京:军事医学科学出版社,2006:296-312.
  • 8Tso MOM.Clinical application and biological basis of therapeutic effects//Tso MOM.Retinal photocoagulation therapy.Philadelphia:J B Lippincott Company,1988:247-262.
  • 9Silva PS,Sun JK,Aiello LP.Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.Semin Ophthalmol,2009,24:93-99.
  • 10Yilmaz T,Weaver CD,Gallagher MJ,et al.Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema:a systematic review.Ophthalmology,2009,116:902-911.

共引文献188

同被引文献133

引证文献14

二级引证文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部